Cargando…
Intravitreal Bevacizumab with or without Triamcinolone for Refractory Diabetic Macular Edema: Long-term Results of a Clinical Trial
PURPOSE: To report the long-term results of intravitreal bevacizumab (IVB) injection alone or combined, at the time of first IVB injection, with intravitreal triamcinolone acetonide (IVT) for treatment of refractory diabetic macular edema (DME). METHODS: In this randomized clinical trial, 115 eyes o...
Autores principales: | Shoeibi, Nasser, Ahmadieh, Hamid, Entezari, Morteza, Yaseri, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ophthalmic Research Center
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740475/ https://www.ncbi.nlm.nih.gov/pubmed/23943683 |
Ejemplares similares
-
Intravitreal Triamcinolone Reinjection for Refractory Diabetic Macular Edema
por: Ramezani, Alireza, et al.
Publicado: (2006) -
Intravitreal Bevacizumab for Treatment of Refractory Central Serous Choroidoretinopathy
por: Entezari, Morteza, et al.
Publicado: (2012) -
Diabetic Macular Edema Before and After Intravitreal Triamcinolone Injection
por: Ramezani, Alireza, et al.
Publicado: (2007) -
Photodynamic Therapy and Intravitreal Bevacizumab with Versus without Triamcinolone for Neovascular Age-related Macular Degeneration; a Randomized Clinical Trial
por: Piri, Niloofar, et al.
Publicado: (2014) -
Resolution of macular edema in Coats' disease with intravitreal bevacizumab
por: Entezari, Morteza, et al.
Publicado: (2010)